Markets
About
One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions. This leaves over 2 million patients living with heart failure, suffering from painful edema and respiratory distress while walking or even laying down to sleep. Medication is no longer effective for them, but they are not sick enough to warrant invasive or dangerous treatments, such as Left Ventricular Assist Devices (LVADs), transplants, or inotropes. Procyrion Inc, (Houston, TX) has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting fluid imbalance.